Showing results (961-970 of 4,874) with videos related to

Sort By:
Pageof 488
Urologic Oncology|November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorshipPatrick J Hensley, Zhigang Duan, Kelly Bree, et al.
Urologic Oncology|January 26, 2023
Age related differences in primary testicular lymphoma: A population based cohort studyMohamad B Berjaoui, Jaime O Herrera-Caceres, Tiange Li, et al.
Urologic Oncology|December 10, 2025
Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancerLuca Afferi, Angelo Territo, Andrea Gallioli, et al.
Urologic Oncology|October 2, 2012
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidenceBrandon L Pierce
Urologic Oncology|October 9, 2012
Integration of immunotherapy into the management of advanced prostate cancerPhilip Kantoff, Celestia S Higano
Urologic Oncology|July 27, 2020
Pseudouridine as a novel biomarker in prostate cancerJennifer A Stockert, Rachel Weil, Kamlesh K Yadav, et al.
Urologic Oncology|July 27, 2020
Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapyMasaki Shiota, Satoshi Endo, Naohiro Fujimoto, et al.
Urologic Oncology|August 11, 2020
Complete response to immune checkpoint inhibitors-based therapy in advanced renal cell carcinoma patients. A meta-analysis of randomized clinical trialsR Iacovelli, C Ciccarese, F A Schutz, et al.
Urologic Oncology|July 14, 2020
Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective studyAmr A Elsawy, Ahmed M Harraz, Fady K Ghobrial, et al.
Urologic Oncology|July 14, 2020
Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic reviewKeiichiro Mori, Noriyoshi Miura, Marek Babjuk, et al.
Pageof 488